SEO URLwww.firestrike.ai/deals/psyga-bio-xtl-biopharmaceuticals-acquisition-2026
acquisitionAnnounced · Apr 30, 2026BiotechnologySource · SpeculativeArticle · Factual
XTL Biopharmaceuticals acquires Psyga Bio
David Najork · Founding Software Engineer
Announced · Updated · 1 min read
Deal value
—
Target
Psyga Bio
Caesarea
Acquirer
XTL Biopharmaceuticals
Full Acquisition
Status
Announced
XTL Biopharmaceuticals agreed to acquire Psyga Bio. Reported deal value: Undisclosed. Status: Announced. Sector: Biotechnology. Target headquarters context: Caesarea, Israel.
This page summarizes publicly available information about the transaction as of 2026-04-30. Figures and status may change as filings and press coverage update.
XTL Biopharmaceuticals To Acquire Psyga Bio To Establish Leading Psychedelic Biotechnology Platform By Amit Chowdhry
Deal timeline
Announced
Apr 30, 2026 · pulse2.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in Biotechnology. Figures and status may change as sources update.
Sources: pulse2.com · Primary article · FireStrike proprietary index